1. Home
  2. WEST vs ESPR Comparison

WEST vs ESPR Comparison

Compare WEST & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WEST
  • ESPR
  • Stock Information
  • Founded
  • WEST 2009
  • ESPR 2008
  • Country
  • WEST United States
  • ESPR United States
  • Employees
  • WEST N/A
  • ESPR N/A
  • Industry
  • WEST Beverages (Production/Distribution)
  • ESPR Biotechnology: Pharmaceutical Preparations
  • Sector
  • WEST Consumer Staples
  • ESPR Health Care
  • Exchange
  • WEST Nasdaq
  • ESPR Nasdaq
  • Market Cap
  • WEST 512.4M
  • ESPR 534.3M
  • IPO Year
  • WEST N/A
  • ESPR 2013
  • Fundamental
  • Price
  • WEST $4.50
  • ESPR $3.12
  • Analyst Decision
  • WEST Strong Buy
  • ESPR Buy
  • Analyst Count
  • WEST 4
  • ESPR 6
  • Target Price
  • WEST $10.00
  • ESPR $6.50
  • AVG Volume (30 Days)
  • WEST 540.9K
  • ESPR 7.2M
  • Earning Date
  • WEST 11-06-2025
  • ESPR 11-06-2025
  • Dividend Yield
  • WEST N/A
  • ESPR N/A
  • EPS Growth
  • WEST N/A
  • ESPR N/A
  • EPS
  • WEST N/A
  • ESPR N/A
  • Revenue
  • WEST $944,492,000.00
  • ESPR $268,125,000.00
  • Revenue This Year
  • WEST $28.24
  • ESPR $13.05
  • Revenue Next Year
  • WEST $9.81
  • ESPR N/A
  • P/E Ratio
  • WEST N/A
  • ESPR N/A
  • Revenue Growth
  • WEST 13.05
  • ESPR N/A
  • 52 Week Low
  • WEST $4.58
  • ESPR $0.69
  • 52 Week High
  • WEST $8.29
  • ESPR $3.94
  • Technical
  • Relative Strength Index (RSI)
  • WEST 31.77
  • ESPR 74.08
  • Support Level
  • WEST $4.59
  • ESPR $2.35
  • Resistance Level
  • WEST $5.08
  • ESPR $3.41
  • Average True Range (ATR)
  • WEST 0.27
  • ESPR 0.17
  • MACD
  • WEST 0.01
  • ESPR 0.00
  • Stochastic Oscillator
  • WEST 0.55
  • ESPR 74.06

About WEST Westrock Coffee Company

Westrock Coffee Co is an integrated coffee, tea, flavors, extracts, and ingredients solutions provider in the U.S, providing coffee sourcing, supply chain management, product development, roasting, packaging, and distribution services to retail, foodservice and restaurant, convenience store and travel center, non-commercial account, CPG, and hospitality industries around the world. The company's segment includes Beverage Solutions and Sustainable Sourcing and Traceability. It generates maximum revenue from the Beverage Solutions segment.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: